Wpływ mikrobioty jelitowej i składników mineralnych na rozwój otyłości

World Health Organisation. Obesity and Overweight. World Health Organisation. Published June 9, 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB. Obesity as a Disease: The Obesity Society 2018 Position Statement. Obesity. 2018;27(1):7-9. doi:https://doi.org/10.1002/oby.22378

‌

Marques A, Peralta M, Naia A, Loureiro N, de Matos MG. Prevalence of adult overweight and obesity in 20 European countries, 2014. European Journal of Public Health. 2017;28(2):295-300. doi:https://doi.org/10.1093/eurpub/ckx143

‌

Stepaniak U, Micek A, Waśkiewicz A, et al. Prevalence of general and abdominal obesity and overweight among adults in Poland. Results of the WOBASZ II study (2013–2014) and comparison with the WOBASZ study (2003–2005). Polish Archives of Internal Medicine. Published online August 18, 2016. doi:https://doi.org/10.20452/pamw.3499

‌

Obesity rate by body mass index (BMI) (sdg_02_10). ec.europa.eu. Accessed February 22, 2023. https://ec.europa.eu/eurostat/cache/metadata/en/sdg_02_10_esmsip2.htm

‌

NEEL JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”?. American journal of human genetics. 1962;14(4):353-362. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1932342/

‌

Hales CN, Barker DJ. The thrifty phenotype hypothesis. British medical bulletin. 2001;60(1):5-20. doi:https://doi.org/10.1093/bmb/60.1.5

‌

Jéquier E. Pathways to obesity. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity. 2002;26 Suppl 2:S12-17. doi:https://doi.org/10.1038/sj.ijo.0802123

‌

Di Angelantonio E, Bhupathiraju SN, Wormser D, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. The Lancet. 2016;388(10046):776-786. doi:https://doi.org/10.1016/s0140-6736(16)30175-1

‌

Aune D, Sen A, Prasad M, et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. Published online May 4, 2016:i2156. doi:https://doi.org/10.1136/bmj.i2156

Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetologica. 2011;48(4):257-273. doi:https://doi.org/10.1007/s00592-011-0333-6

‌

Stappenbeck TS, Hooper LV, Gordon JI. Nonlinear partial differential equations and applications: Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proceedings of the National Academy of Sciences. 2002;99(24):15451-15455. doi:https://doi.org/10.1073/pnas.202604299

Cheng Z, Zhang L, Yang L, Chu H. The critical role of gut microbiota in obesity. Frontiers in Endocrinology. 2022;13. doi:https://doi.org/10.3389/fendo.2022.1025706

‌

Xu J, Gordon JI. Honor thy symbionts. Proceedings of the National Academy of Sciences. 2003;100(18):10452-10459. doi:https://doi.org/10.1073/pnas.1734063100

‌

Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-1031. doi:https://doi.org/10.1038/nature05414

‌

Jumpertz R, Le DS, Turnbaugh PJ, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. The American Journal of Clinical Nutrition. 2011;94(1):58-65. doi:https://doi.org/10.3945/ajcn.110.010132

‌

1.Xu Y, Wang N, Tan HY, Li S, Zhang C, Feng Y. Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems. Frontiers in Microbiology. 2020;11(219). doi:https://doi.org/10.3389/fmicb.2020.00219

‌18. Dao MC, Everard A, Aron-Wisnewsky J, et al. Akkermansia muciniphilaand improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2015;65(3):426-436. doi:https://doi.org/10.1136/gutjnl-2014-308778

Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine. 2019;25(7):1096-1103. doi:https://doi.org/10.1038/s41591-019-0495-2

‌

Fredrik Bäckhed, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences. 2007;104(3):979-984. doi:https://doi.org/10.1073/pnas.0605374104

‌

Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-1031. doi:https://doi.org/10.1038/nature05414

‌

Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut Microbiome. Cell Host & Microbe. 2008;3(4):213-223. doi:https://doi.org/10.1016/j.chom.2008.02.015

‌‌

Marlicz W, Ostrowska L, Łoniewski I. Intestinal microbiota and its potential relationship with obesity. Endocrinology, Obesity and Metabolic Disorders. 2013;9(1):20-28. Accessed February 22, 2023. https://journals.viamedica.pl/eoizpm/article/view/34276

Brandt LJ, Aroniadis OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointestinal Endoscopy. 2013;78(2):240-249. doi:https://doi.org/10.1016/j.gie.2013.03.1329

‌

Haifer C, Kelly CR, Paramsothy S, et al. Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut. 2020;69(5):801-810. doi:https://doi.org/10.1136/gutjnl-2019-320260

‌

Lee P, Yacyshyn BR, Yacyshyn MB. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT). Diabetes, Obesity and Metabolism. 2018;21(3):479-490. doi:https://doi.org/10.1111/dom.13561

‌

Kellermayer R. Prospects and challenges for intestinal microbiome therapy in pediatric gastrointestinal disorders. World Journal of Gastrointestinal Pathophysiology. 2013;4(4):91. doi:https://doi.org/10.4291/wjgp.v4.i4.91

‌

Baxter M, Ahmad T, Colville A, Sheridan R. Fatal Aspiration Pneumonia as a Complication of Fecal Microbiota Transplant. Clinical Infectious Diseases. 2015;61(1):136-137. doi:https://doi.org/10.1093/cid/civ247

‌

DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. New England Journal of Medicine. Published online October 30, 2019. doi:https://doi.org/10.1056/nejmoa1910437

‌

Hohmann EL, Ananthakrishnan AN, Deshpande V. Case 25-2014. Cabot RC, Rosenberg ES, Harris NL, et al., eds. New England Journal of Medicine. 2014;371(7):668-675. doi:https://doi.org/10.1056/nejmcpc1400842

‌

Moayyedi P, Surette MG, Kim PT, et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015;149(1):102-109.e6. doi:https://doi.org/10.1053/j.gastro.2015.04.001

‌

Sbahi H, Di Palma JA. Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterology. 2016;3(1):e000087. doi:https://doi.org/10.1136/bmjgast-2016-000087

‌

Li M, Liang P, Li Z, et al. Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis. Frontiers in Microbiology. 2015;6. doi:https://doi.org/10.3389/fmicb.2015.00692

‌

Gagliardi A, Totino V, Cacciotti F, et al. Rebuilding the Gut Microbiota Ecosystem. International Journal of Environmental Research and Public Health. 2018;15(8):1679. doi:https://doi.org/10.3390/ijerph15081679

‌

Skalny AV, Aschner M, Lei XG, et al. Gut Microbiota as a Mediator of Essential and Toxic Effects of Zinc in the Intestines and Other Tissues. International Journal of Molecular Sciences. 2021;22(23):13074. doi:https://doi.org/10.3390/ijms222313074

‌

Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage. 2011;1(2):111-114. doi:https://doi.org/10.4161/bact.1.2.14590

‌

Zhang H, Cai L. Zinc homeostasis plays an important role in the prevention of obesity-induced cardiac inflammation, remodeling and dysfunction. Journal of Trace Elements in Medicine and Biology. 2020;62:126615. doi:https://doi.org/10.1016/j.jtemb.2020.126615

‌

Gomes C de C, Passos TS, Morais AHA. Vitamin A Status Improvement in Obesity: Findings and Perspectives Using Encapsulation Techniques. Nutrients. 2021;13(6):1921. doi:https://doi.org/10.3390/nu13061921

‌

Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK. Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed: Medscape General Medicine. 2006;8(4):59. Accessed January 9, 2021. https://pubmed.ncbi.nlm.nih.gov/17415336/

‌

García OP, Long KZ, Rosado JL. Impact of micronutrient deficiencies on obesity. Nutrition Reviews. 2009;67(10):559-572. doi:https://doi.org/10.1111/j.1753-4887.2009.00228.x

‌

Andersen LF, Jacobs DR, Gross MD, Schreiner PJ, Dale Williams O, Lee DH. Longitudinal associations between body mass index and serum carotenoids: the CARDIA study. British Journal of Nutrition. 2006;95(2):358-365. doi:https://doi.org/10.1079/bjn20051638

‌

Coronel J, Pinos I, Amengual J. β-carotene in Obesity Research: Technical Considerations and Current Status of the Field. Nutrients. 2019;11(4):842. doi:https://doi.org/10.3390/nu11040842

‌

BARREA L, FRIAS-TORAL E, PUGLIESE G, et al. Vitamin D in obesity and obesity-related diseases: an overview. Minerva Endocrinology. 2021;46(2). doi:https://doi.org/10.23736/s2724-6507.20.03299-x

‌

Knutsen KV, Brekke M, Gjelstad S, Lagerløv P. Vitamin D status in patients with musculoskeletal pain, fatigue and headache: A cross-sectional descriptive study in a multi-ethnic general practice in Norway. Scandinavian Journal of Primary Health Care. 2010;28(3):166-171. doi:https://doi.org/10.3109/02813432.2010.505407

‌

Lim HH. Commentary on “Low serum 25-hydroxyvitamin D level is associated with obesity and atherogenesis in adolescent boys.” Annals of Pediatric Endocrinology & Metabolism. 2022;27(1):3-4. doi:https://doi.org/10.6065/apem.2221056edi01

Naganuma J, Koyama S, Arisaka O, Yoshihara S. Low serum 25-hydroxyvitamin D level is associated with obesity and atherogenesis in adolescent boys. Annals of Pediatric Endocrinology & Metabolism. 2022;27(1):30-36. doi:https://doi.org/10.6065/apem.2142112.056

‌

Mallard SR, Howe AS, Houghton LA. Vitamin D status and weight loss: a systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials. The American Journal of Clinical Nutrition. 2016;104(4):1151-1159. doi:https://doi.org/10.3945/ajcn.116.136879

‌

Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. International Journal of Obesity. 2011;36(3):387-396. doi:https://doi.org/10.1038/ijo.2011.119

‌

Naderi N, House JD. Recent Developments in Folate Nutrition. Advances in Food and Nutrition Research. Published online 2018:195-213. doi:https://doi.org/10.1016/bs.afnr.2017.12.006

‌

Zhao M, Yuan MM, Yuan L, et al. Chronic folate deficiency induces glucose and lipid metabolism disorders and subsequent cognitive dysfunction in mice. Nerurkar PV, ed. PLOS ONE. 2018;13(8):e0202910. doi:https://doi.org/10.1371/journal.pone.0202910

‌

Bazzano LA, He J, Ogden LG, et al. Dietary Intake of Folate and Risk of Stroke in US Men and Women. Stroke. 2002;33(5):1183-1189. doi:https://doi.org/10.1161/01.str.0000014607.90464.88

‌

Wang LX, Gurka MJ, Deboer MD. Metabolic syndrome severity and lifestyle factors among adolescents. Minerva Pediatrica. 2018;70(5). doi:https://doi.org/10.23736/s0026-4946.18.05290-8